During the past decade, Yaroslavl Regional Clinical Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 15 clinical trials were completed, i.e. on average, 93.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yaroslavl Regional Clinical Hospital" #1 sponsor was "Mannkind Corporation" with 7 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "AOP Orphan Pharmaceuticals AG" with 3 trials sponsored, "Gilead Sciences" with 3 trials sponsored and "Kowa Research Institute, Inc." with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yaroslavl Regional Clinical Hospital" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "EXCELYA Bordeaux" with 1 trials as a collaborator, "Enrollme.ru, LLC" with 1 trials as a collaborator and "Foundation for Cancer Research Support (RakFond)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Yaroslavl Regional Clinical Hospital" are "Arthritis, Psoriatic" (3 trials), "Type 2 Diabetes Mellitus" (3 trials), "Diabetes Type 2" (2 trials), "Polycythemia Vera" (2 trials) and "Psoriatic Arthritis" (2 trials). Many other conditions were trialed in "Yaroslavl Regional Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Yaroslavl Regional Clinical Hospital" are "Drug" (33 trials), "Behavioral" (3 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Guselkumab" (4 trials), "Technosphere Insulin" (4 trials), "Diet" (3 trials) and "Exercise" (3 trials). Other intervention names were less common.

The vast majority of trials in "Yaroslavl Regional Clinical Hospital" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Yaroslavl Regional Clinical Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 29 completed trials in Yaroslavl Regional Clinical Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Yaroslavl Regional Clinical Hospital, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".